David D N'Da (G Terre'Blanche, Gisella Terre'Blanche)

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 10

Top Venues

Molecular diversity

BMC endocrine disorders

Drug and chemical toxicology

Chemicke zvesti

North-West University

North West University School of Pharmacy (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

North-West University

South Africa

Professor :: Pharmaceutical Chemistry

Education History

North West University School of Pharmacy Jan 01 1992 - Jan 01 1998

South Africa

PHD :: Pharmaceutical Chemstry

Publications

Olakunle Sanni, David D N'Da
Dual A 1 and A 2A adenosine receptor antagonists, methoxy substituted 2-benzylidene-1-indanone, suppresses intestinal postprandial glucose and attenuates hyperglycaemia in fructose-streptozotocin diabetic rats. BMC endocrine disorders 23 (1) (2023)
Olakunle Sanni, David D N'Da
Dual A 1 and A 2A adenosine receptor antagonists, methoxy substituted 2-benzylidene-1-indanone, suppresses intestinal postprandial glucose and attenuates hyperglycaemia in fructose-streptozotocin diabetic rats. BMC endocrine disorders 23 (1) (2023)
Olakunle Sanni, David D N'Da, David D N'Da
Insight into the mechanism and toxicology of nitrofurantoin: a metabolomics approach. Drug and chemical toxicology (2023)
Olakunle Sanni, David D N'Da
Dual A 1 and A 2A adenosine receptor antagonists, methoxy substituted 2-benzylidene-1-indanone, suppresses intestinal postprandial glucose and attenuates hyperglycaemia in fructose-streptozotocin diabetic rats. BMC endocrine disorders 23 (1) (2023)
Chrisna Matthee, David D N'Da, Lesetja J Legoabe, Helena D Janse van Rensburg
Correction to: Exploration of chalcones and related heterocycle compounds as ligands of adenosine receptors: therapeutics development. Molecular diversity (2021)
Chrisna Matthee, David D N'Da, Lesetja J Legoabe, Helena D Janse van Rensburg
Exploration of chalcones and related heterocycle compounds as ligands of adenosine receptors: therapeutics development. Molecular diversity (2021)
Nadia Janse van Vuuren, Helena D Janse van Rensburg, David D N'Da, Lesetja J Legoabe
New fused pyrroles with rA1/A2A antagonistic activity as potential therapeutics for neurodegenerative disorders. Molecular diversity (2021)
Olakunle Sanni, David D N'Da
Therapeutic potentials of agonist and antagonist of adenosine receptors in type 2 diabetes. Reviews in endocrine & metabolic disorders (2021)
Helena D Janse van Rensburg, Lesetja J Legoabe, David D N'Da
C3 amino-substituted chalcone derivative with selective adenosine rA1 receptor affinity in the micromolar range. Chemicke zvesti (2020)
Helena D Janse van Rensburg, Lesetja J Legoabe, David D N'Da, Mietha Magdalena van der Walt
Methoxy substituted 2-benzylidene-1-indanone derivatives as A1 and/or A2A AR antagonists for the potential treatment of neurological conditions. MedChemComm 10 (2) (2019)

David D N'Da.css-eqlu8i{font-size:small;padding-left:4px;} (G Terre'Blanche, Gisella Terre'Blanche)

Publication Activity (10 Years)

Top Topics

Top Venues

David D N'Da (G Terre'Blanche, Gisella Terre'Blanche)